- Home
- CLX vs QGEN Comparison
CLX vs QGEN Comparison
Compare CLX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLX | QGEN |
|---|---|---|
| Founded | 1913 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLX | QGEN |
|---|---|---|
| Price | $106.01 | $48.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $126.38 | $47.81 |
| AVG Volume (30 Days) | ★ 2.4M | 1.2M |
| Earning Date | 02-02-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.67% | 3.29% |
| EPS Growth | 121.91 | ★ 331.25 |
| EPS | ★ 6.38 | 1.94 |
| Revenue | ★ $6,771,000,000.00 | $2,070,781,000.00 |
| Revenue This Year | N/A | $7.07 |
| Revenue Next Year | $4.80 | $6.14 |
| P/E Ratio | ★ $16.64 | $24.95 |
| Revenue Growth | N/A | ★ 5.32 |
| 52 Week Low | $96.66 | $39.61 |
| 52 Week High | $164.22 | $54.61 |
Technical Indicators
Market Signals| Indicator | CLX | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 63.00 | 67.70 |
| Support Level | $98.75 | $44.71 |
| Resistance Level | $102.41 | $49.01 |
| Average True Range (ATR) | 2.01 | 0.78 |
| MACD | 0.95 | 0.36 |
| Stochastic Oscillator | 99.47 | 83.95 |
Price Performance
Historical ComparisonAbout CLX Clorox Company (The)
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).